823 e-Letters

  • Didn't help me
    Ellen M Goudsmit

    I have been diagnosed with ME since 1984 and was a patient at the Optimum Health clinic. I found the staff sympathetic but the advice just didn't help.

    Three MRIs have shown increasing demyelination. Brain scans on fellow patients have also identified other abnormalities, e.g. enlarged ventricles. We're not talking about a disorder without evidence of pathology.

    When the NHS shows little interest,...

    Show More
  • Second Reply: A Highly Biased and Flawed Study
    Keith J Geraghty

    Dear Authors,

    Thank you for your response. I have looked even more closely at your paper, it's methodology, and your results, and I stand over my original contention that this is a biased study.

    The primary bias is that Dr. Arroll and Mr. Howard have a vested financial interest in the products being sold, notably psychological support and life coaching and so on. This fact would not preclude an in- hou...

    Show More
  • Re:A Highly Biased and Flawed Study
    Megan A. Arroll

    Dear Dr Geraghty,

    Many thanks for your eletter. We will respond to each of your concerns in turn.

    1. The clinic offers psychological and nutritional approaches for the management of ME/CFS. Individuals do indeed pay for the support offered by the clinic, often because they have felt that the care they have received previously was lacking. Numerous countries offer private care and conduct research on the...

    Show More
  • A Highly Biased and Flawed Study
    Keith Geraghty

    I find this study highly biased and flawed for the following reasons.

    1. Alex Howard is founder of this clinic, which he started some years ago offering counselling and life coaching to people looking for support. Alex Howard runs the OHC as a private enterprise. The term clinic evokes a clinical setting, yet this is a non-clinical business. The term patients is often used by Mr Howard, yet this is a non-clinical...

    Show More
  • Expressed genes in alveolar type II cells.
    Hiroshi Kubo

    Data is available from the Dryad data repository at http://datadryad.org/ with doi:10.5061/dryad.mc4s1.

    Conflict of Interest:

    None declared

  • Hazards of hypnotics probably underestimated
    Daniel F. Kripke

    Daniel F. Kripke, M.D. and Robert D. Langer, M.D., M.P.H.

    This study provides additional evidence that use of hypnotics is significantly associated with future poor health and mortality. The analysis has the strength of evaluating the potentially-confounding roles of sleep duration and subjective insomnia and offers new information about several morbidities predicted by hypnotic use. The presentation gives con...

    Show More
  • Metformin is a safe medication in mild-to-moderate chronic kidney disease.
    David Arroyo

    Dear Editor,

    Ekstrom and colleagues publish a very interesting observational study comparing the rates of various outcomes depending on the type of antidiabetic drug prescribed.(1) This large population-based study presents some limitations, such as baseline difference between groups, attributing outcomes to initial treatment regardless of changes over time, or grouping diverse outcomes such as acidosis and infec...

    Show More
  • Data mapping for GPs
    Ditch Townsend

    We are not aware of any primary care trusts (PCTs) or emerging clinical commissioning groups (CCGs) who regularly provide a range of detailed data on health by lower level super-output area (LSOA). We became aware of this paper on 15th June 2012 having already begun to consider ways to map general practice (GP) Quality Outcomes Framework (QOF) data by LSOA. The paper's conclusions presented us with useful indicators of ef...

    Show More
  • Life expectancy record holders have about average life disparity levels at each life expectancy level
    Alyson A. van Raalte

    Alyson A. van Raalte, James W. Vaupel, Zhen Zhang

    Monden and Smits raise a valid point that "the countries that reached a certain e(0) first are not the most equal countries at that level of e(0)" [1]. We do not dispute this. In fact, we performed a similar analysis in the supporting material (Figure S4) [2]. At each e(0) level, our figure compared the life disparity level of e(0) leaders to the average life...

    Show More
  • Important errors in "Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review" by Farrimond et al.
    George T. Grossberg

    George T. Grossberg, MD, St. Louis University School of Medicine, St Louis, Missouri, USA

    Yvonne Wirth, MD, PhD, Wirth Consulting, Stuttgart, Germany

    Suzanne Hendrix, PhD, Pentara Corporation, Salt Lake City, Utah, USA

    Michael Tocco, PhD, Forest Research Institute, Jersey City, New Jersey, USA

    Stephen M. Graham, PhD, Forest Research Institute, Jersey City, New Jersey, USA


    Show More